Biotechnology

New patent expiration for the drug Astrazeneca Ab BYDUREON PEN

[ad_1]

New patent expiration for the drug Astrazeneca Ab BYDUREON PEN

Annual Drug Patent Expiration for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and included in one NDA. It is available from a single supplier. There are twenty two…

Post New patent expiration for the drug Astrazeneca Ab BYDUREON PEN appeared the first time DrugPatentWatch – Making Better Decisions.


Comments are closed.

[ad_2]

Source link

Related Articles

Back to top button